Analytical Data
-
Gene name
MIF4GD
- Application
-
Alternative Names
MIF4GD;SLIP1;MIF4G domain-containing Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A9UHW6
-
Expression Region
1-222aa
-
AA Sequence
MGEPSREEYK IQSFDAETQQ LLKTALKDPG AVDLEKVANV IVDHSLQDCV FSKEAGRMCY AIIQAESKQA GQSVFRRGLL NRLQQEYQAR EQLRARSLQG WVCYVTFICN IFDYLRVNNM PMMALVNPVY DCLFRLAQPD SLSKEEEVDC LVLQLHRVGE QLEKMNGQRM DELFVLIRDG FLLPTGLSSL AQLLLLEIIE FRAAGWKTTP AAHKYYYSEV SD
-
Molecular Weight
25.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MIF4GD (Macrophage Migration Inhibitory Factor 4 Gene-Derived) is a protein that has garnered attention in recent years due to its potential role in various biological processes and diseases. Research has indicated that MIF4GD may play a significant part in immune response regulation, inflammation, and cellular signaling pathways. Its expression is often altered in pathological conditions, suggesting a possible involvement in cancer progression, autoimmune disorders, and metabolic diseases. Given the increasing prevalence of these diseases globally, understanding the functional mechanisms of MIF4GD is crucial for the development of novel therapeutic approaches. Moreover, recombinant expression of MIF4GD allows researchers to investigate its properties and interactions in detail, facilitating insights into its biological roles and potential as a biomarker or therapeutic target. The study of MIF4GD is emerging as a valuable avenue in molecular biology and medicine, promoting further exploration into its structure-function relationship and implications in health and disease.











